<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes - Brown, J - 2016 | Cochrane Library</title> <meta content="Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes - Brown, J - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012048.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes - Brown, J - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012048.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD012048.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes" name="citation_title"/> <meta content="Julie Brown" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="j.brown@auckland.ac.nz" name="citation_author_email"/> <meta content="Tineke J Crawford" name="citation_author"/> <meta content="The University of Auckland" name="citation_author_institution"/> <meta content="Jane Alsweiler" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Caroline A Crowther" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD012048.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/09/07" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012048.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012048.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012048.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD012048.pub2&amp;doi=10.1002/14651858.CD012048.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="18M35a5z";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD012048\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD012048\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","th","ja","fr","pl","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD012048.pub2",title:"Dietary supplementation with myo\\u2010inositol in women during pregnancy for treating gestational diabetes",firstPublishedDate:"Sep 7, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012048.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012048.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD012048.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD012048.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012048.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD012048.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD012048.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD012048.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD012048.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD012048.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10855 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD012048.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0132"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0099"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-sec-0126"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/appendices#CD012048-sec-0137"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/table_n/CD012048StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/table_n/CD012048StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dietary supplementation with myo‐inositol in women during pregnancy for treating gestational diabetes </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#CD012048-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Julie Brown</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#CD012048-cr-0003">Tineke J Crawford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#CD012048-cr-0004">Jane Alsweiler</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information#CD012048-cr-0005">Caroline A Crowther</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information/en#CD012048-sec-0140">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 07 September 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD012048.pub2">https://doi.org/10.1002/14651858.CD012048.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD012048-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012048-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD012048-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012048-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012048-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012048-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/th#CD012048-abs-0002">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD012048-abs-0001" lang="en"> <section id="CD012048-sec-0001"> <h3 class="title" id="CD012048-sec-0001">Background</h3> <p>Gestational diabetes mellitus (GDM) is any degree of glucose intolerance that first presents and is recognised during pregnancy and usually resolves after the birth of the baby. GDM is associated with increased short‐ and long‐term morbidity for the mother and her baby. Treatment usually includes lifestyle modification and/or pharmacological therapy (oral antidiabetic agents or insulin) with the aim to maintain treatment targets for blood glucose concentrations. Finding novel treatment agents which are effective, acceptable and safe for the mother and her baby are important. One such emerging potential intervention is myo‐inositol which is an isomer of inositol and occurs endogenously and is found in natural dietary sources such as fruits, vegetables, nuts and cereals. </p> </section> <section id="CD012048-sec-0002"> <h3 class="title" id="CD012048-sec-0002">Objectives</h3> <p>To assess if dietary supplementation with myo‐inositol during pregnancy is safe and effective, for the mother and fetus, in treating gestational diabetes. </p> </section> <section id="CD012048-sec-0003"> <h3 class="title" id="CD012048-sec-0003">Search methods</h3> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (30 April 2016), <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (7 April 2016), and reference lists of retrieved studies. </p> </section> <section id="CD012048-sec-0004"> <h3 class="title" id="CD012048-sec-0004">Selection criteria</h3> <p>All published and unpublished randomised controlled trials or cluster‐randomised controlled trials reporting on the use of myo‐inositol compared with placebo, no treatment or another intervention for the treatment of women with gestational diabetes. Quasi‐randomised and cross‐over studies are not eligible for inclusion. Women with pre‐existing diabetes were excluded. </p> </section> <section id="CD012048-sec-0005"> <h3 class="title" id="CD012048-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. For key outcomes (where data were available), we assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD012048-sec-0006"> <h3 class="title" id="CD012048-sec-0006">Main results</h3> <p>We included two studies (142 women and infants), both were conducted in women in Italy and compared myo‐inositol with a placebo control. </p> <p>None of the maternal primary outcomes pre‐specified for this review were reported in the included studies: <b>hypertensive disorders of pregnancy</b> ; <b>caesarean section</b> ; <b>development of subsequent type 2 diabetes mellitus</b>. No data were reported for the majority of this review's maternal secondary outcomes. We could only perform meta‐analysis for two secondary outcomes: fasting oral glucose tolerance test and additional pharmacological treatment. All other results are based on data from single studies. Overall, the risk of bias of the included studies was judged to be unclear due to lack of key methodological information. </p> <p>There was no evidence of a difference between treatment groups in need for additional pharmacotherapy or weight gain during pregnancy, although myo‐inositol was associated with a lower body mass index (BMI) change (mean difference (MD) ‐1.50 kg/m<sup>2</sup>; 95% confidence interval (CI) ‐2.35 to ‐0.65; one trial, n = 73). Myo‐inositol was associated with a reduction in the fasting blood glucose concentration at the end of treatment (MD ‐0.47 mmol/L; 95% CI ‐0.59 to ‐0.35; two trials, n = 142 women) compared with the control group. One small trial reported that myo‐inositol was associated with a reduction in one‐hour post‐prandial blood glucose concentration at the end of treatment (MD ‐0.90 mmol/L; 95% CI ‐1.73 to ‐0.07; one trial, n = 73 women) compared with the control group. There was no difference between groups for the two‐hour post‐prandial blood glucose concentrations between groups (MD ‐0.70 mmol/L; 95% CI ‐1.46 to 0.06; one trial, n = 73 women). The one‐hour and two‐hour blood glucose concentrations show evidence of imprecision associated with wide CIs and small sample size. </p> <p>For the infant, there was no evidence of a difference in the risk for being born <b>large‐for‐gestational age</b> between the myo‐inositol and the control group (risk ratio (RR) 0.36; 95% CI 0.02 to 8.58; one trial, n = 73 infants; <i>low‐quality evidence</i>). The evidence was downgraded due to imprecision. This review's other primary outcomes were not reported in the included trials: <b>perinatal mortality (stillbirth and neonatal mortality)</b> ; <b>mortality of morbidity composite</b> (as defined by the trials); <b>neurosensory disability</b>. Infants in the myo‐inositol group were less likely to have neonatal hypoglycaemia compared with the placebo group (RR 0.05; 95% CI 0.00 to 0.85; one study, n = 73 infants; <i>low‐quality evidence</i>). There is evidence of imprecision for this outcome with low event rates and small sample size. There was no evidence of a difference between treatment and placebo groups for preterm birth or birthweight. Myo‐inositol was associated with a later gestational age at birth compared with the placebo group (MD 2.10 weeks; 95% CI 1.27 to 2.93; one trial, n = 73 infants). No data were reported for any of the other neonatal outcomes for this review. </p> <p>No long‐term outcomes were reported for the mother, infant as a child, infant as an adult, or health service outcomes. </p> </section> <section id="CD012048-sec-0007"> <h3 class="title" id="CD012048-sec-0007">Authors' conclusions</h3> <p>There are insufficient data to evaluate the effect of myo‐inositol for the treatment of gestational diabetes, with no data to examine the majority of outcomes in this review. There do not appear to be any benefits for the infant associated with exposure to myo‐inositol such as reduced risk of being born large‐for‐gestational age. Although the risk of neonatal hypoglycaemia is reduced for the myo‐inositol group, there is evidence of imprecision. Evidence from two studies suggested that myo‐inositol was associated with a reduced change in maternal BMI and fasting blood sugar concentration compared with placebo. There is a lack of reporting of the clinically meaningful outcomes pre‐specified for this review. </p> <p>Uncertainty of the effectiveness of myo‐inositol as a treatment for GDM for key maternal and infant outcomes remains and further high‐ quality trials with appropriate sample sizes are required to further investigate the role of myo‐inositol as a treatment or co‐treatment for women with gestational diabetes. Future trials should report on the core outcomes for GDM identified in the methods section of this review. Participants of varying ethnicities and with varying risk factors for GDM should be included in future trials. In addition, further trials of myo‐inositol for the treatment of GDM should explore the optimal dose, frequency and timing of supplementation, report on adverse effects and assess the long‐ term effects of this intervention. Economic analysis or health service use and costs should also be included. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD012048-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD012048-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD012048-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD012048-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD012048-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD012048-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD012048-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD012048-abs-0016">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD012048-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD012048-abs-0008">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD012048-abs-0009">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD012048-abs-0006" lang="en"> <h3>Does taking a supplement of myo‐inositol work as an effective treatment for women who develop diabetes during pregnancy? </h3> <p><b>What is the issue?</b> </p> <p>During pregnancy the mother develops resistance to insulin and the uptake of glucose from the blood is reduced to ensure the baby has a consistent supply of glucose. The mother has to produce extra insulin to keep her blood glucose levels under control or she is at risk of developing gestational diabetes mellitus (GDM). GDM is diabetes that occurs during pregnancy and resolves after the birth of the baby. It is an increasing problem around the world, causing both long‐ and short‐term complications for the mother and her baby. Women with GDM are at greater risk of developing high blood pressure and having a caesarean section for the birth. Their babies can grow large for their gestational age, which increases the likelihood of having an injury at birth such as broken bones or a shoulder becoming stuck. In the long term both the mother and her child are at increased risk of developing type 2 diabetes. </p> <p><b>Why is this important?</b> </p> <p>Dietary and lifestyle counselling is the first line of treatment for women with GDM. An oral hypoglycaemic drug or insulin therapy is recommended for the women who are still unable to maintain target blood glucose levels. Finding a treatment that controls the mother’s blood sugar levels without harming the mother or her baby is important. Myo‐inositol is a natural form of inositol that is found in fruits, vegetables, nuts and cereals. It is a simple carbohydrate nutrient the body requires for many cell functions. Myo‐inositol is available as a dietary supplement, in water‐soluble powder form or as capsules. </p> <p><b>What evidence did we find?</b> </p> <p>We searched for evidence in April 2016 and identified two randomised controlled studies (involving 142 women and their babies). Both studies were conducted in Italy (and were judged to be at an unclear risk of bias). The women were diagnosed with GDM at 12 to 13 weeks' gestation in one study and at 26 weeks' gestation in the other. The findings from these trials suggested that myo‐inositol can reduce fasting blood glucose levels. The need for supplementary insulin was not clearly different between the women receiving myo‐inositol and the control groups. One of the studies showed reduced glucose levels at one hour after a meal (one study, 73 women) There was no evidence to suggest that the babies were at reduced risk of being born large‐for‐gestational age (one study, 73 infants). Myo‐inositol appeared to reduce the risk of the baby having low blood sugar levels at birth and being born at a later gestational age, although the evidence was of low quality. Many of the infant and maternal outcomes identified as being of interest for this review were not reported in the included studies ‐ these included: high blood pressure during the pregnancy, caesarean section, the development of type 2 diabetes (maternal), and the number of babies who died or were unwell, or the number of babies with neurosensory disability. No long‐term outcomes were reported for the mother, infant as a child, infant as an adult or health service outcomes. </p> <p><b>What does this mean?</b> </p> <p>Because of the limited number of studies reporting on myo‐inositol for the treatment of women with GDM, lack of data on the outcomes of importance for this review and the low‐quality evidence based on two small studies, we cannot be certain if myo‐inositol is useful as a treatment intervention for women with GDM. The available evidence is insufficient to support the use of myo‐inositol. Further high‐quality trials with large sample sizes are required to investigate the role of myo‐inositol as a treatment or a co‐treatment for women with gestational diabetes. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD012048-sec-0132" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD012048-sec-0132"></div> <h3 class="title" id="CD012048-sec-0133">Implications for practice</h3> <section id="CD012048-sec-0133"> <p>There is currently insufficient evidence on the use of myo‐inositol for the treatment of gestational diabetes mellitus (GDM) to support its use. Uncertainty remains around adverse effects, as these outcomes are not reported in the included trials. </p> </section> <h3 class="title" id="CD012048-sec-0134">Implications for research</h3> <section id="CD012048-sec-0134"> <p>There is uncertainty regarding the use of myo‐inositol for the treatment of GDM. This is mainly due to insufficient data and lack of reporting of clinically meaningful outcomes for women with GDM and their babies. Further trials are required that look at the role of myo‐inositol for the treatment or co‐treatment of GDM that report on the core outcomes for GDM identified in the methods section of this review. Participants of varying ethnicities and with varying risk factors for GDM should be included in future trials. In addition, further trials of myo‐inositol for the treatment of GDM should explore the optimal dose, frequency and timing of supplementation, report on adverse effects and assess the long‐term effects of this intervention. Economic analysis or health service use and costs should also be included. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD012048-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD012048-sec-0043"></div> <div class="table" id="CD012048-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Setting:</b> women were out‐patients attending a high risk pregnancy unit at hospitals in Italy. </p> <p><b>Patient or population:</b> pregnant women with gestational diabetes<br/> <b>Intervention:</b> 4 g myo‐inositol + 400 mcg folic acid orally per day (dosage regimen not stated), and exercise and dietary advice (n = 36)<br/> <b>Comparison:</b> placebo 400 mcg folic acid orally per day, and exercise and dietary advice (n = 39) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Myo‐inositol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (1 to 226) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.36<br/> (0.02 to 8.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low event rates and small sample size indicate imprecision. 0/35 events in myo‐inositol group and 1/38 events in the placebo group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perinatal mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal hypoglycaemia</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (0 to 224) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.05<br/> (0.00 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low event rates and small sample size indicate imprecision. 0/35 events in myo‐inositol group and 10/38 events in the placebo group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Composite outcome of serious neonatal outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Childhood/adulthood adiposity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Childhood/adulthood diabetes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurosensory disability</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Small sample size, single trial and low events indicate imprecision ‐ downgraded ‐ 2 levels </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD012048-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Setting:</b> women were out‐patients attending a high risk pregnancy unit at a hospital in Italy. </p> <p><b>Patient or population:</b> pregnant women with gestational diabetes<br/> <b>Intervention:</b> 4 g myo‐inositol + 400 mcg folic acid orally per day (dosage regimen not stated), and exercise and dietary advice (n = 36)<br/> <b>Comparison:</b> placebo 400 mcg folic acid orally per day, and exercise and dietary advice (n = 39) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Myo‐inositol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertensive disorders of pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Induction of labour</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perineal trauma</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal weight retention/return to pre‐pregnancy weight</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal depression</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Development of subsequent type 2 diabetes mellitus</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD012048-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD012048-sec-0044"></div> <section id="CD012048-sec-0045"> <h3 class="title" id="CD012048-sec-0045">Description of the condition</h3> <p>Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance with onset or first recognition during pregnancy (<a href="./references#CD012048-bbs2-0008" title="AlbertiK , ZimmetP . Definition, diagnosis and classification of diabetes mellitus. Part 1: Diagnosis and classification of diabetes mellitus: World Health Organization Report. Diabetic Medicine1998;15(7):539‐53. ">Alberti 1998</a>). During pregnancy, the placenta releases hormones that increase maternal insulin resistance to ensure a consistent supply of glucose to the growing fetus (<a href="./references#CD012048-bbs2-0028" title="McCanceDR . Pregnancy and diabetes. Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism2011;25:945‐58. ">McCance 2011</a>). In compensation for this, the maternal pancreas secretes more insulin to maintain glycaemic control. Gestational diabetes occurs when this compensatory mechanism malfunctions and there is not enough insulin for appropriate glucose metabolism (<a href="./references#CD012048-bbs2-0029" title="McCurdyC , FriedmanJ . Mechanisms underlying insulin resistance in human pregnancy and gestational diabetes mellitus. In: KimK , FerraraA editor(s). Gestational Diabetes During and After Pregnancy. London: Springer, 2010:125‐38. ">McCurdy 2010</a>). This results in increased maternal blood glucose concentrations, or hyperglycaemia, and an increased amount of glucose crossing the placenta, over‐nourishing the fetus (<a href="./references#CD012048-bbs2-0029" title="McCurdyC , FriedmanJ . Mechanisms underlying insulin resistance in human pregnancy and gestational diabetes mellitus. In: KimK , FerraraA editor(s). Gestational Diabetes During and After Pregnancy. London: Springer, 2010:125‐38. ">McCurdy 2010</a>). </p> <p>The diagnosis of GDM is usually made using an oral glucose tolerance test (OGTT) between 24 to 28 weeks' gestation. The diagnostic criteria vary from country to country (<a href="./references#CD012048-bbs2-0006" title="American College of Obstetricians and Gynecologists. Gestational Diabetes Mellitus: Practice Bulletin Number 137. Obstetrics and Gynecology2013;122(2 Pt 1):406‐16. ">ACOG 2013</a>; <a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>; <a href="./references#CD012048-bbs2-0013" title="Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2008;32(Suppl 1):S1‐S201. ">CDA 2008</a>; <a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>; <a href="./references#CD012048-bbs2-0032" title="NankervisA , McIntyreHD , MosesR , RossGP , CallawayL , PorterC , et al. for the Australasian Diabetes in Pregnancy Society (ADIPS). Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia. URL: http://adips.org/downloads/ADIPSConsensusGuidelinesGDM‐03.05.13VersionACCEPTEDFINAL.pdf (accessed 03 July 2015). ">Nankervis 2013</a>; <a href="./references#CD012048-bbs2-0035" title="National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre‐conception to the Postnatal Period. Manchester: NICE, 2015. ">NICE 2015</a>; <a href="./references#CD012048-bbs2-0034" title="New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014. ">New Zealand Ministry of Health 2014</a>) (<a href="#CD012048-tbl-0003">Table 1</a>), making overall estimates of prevalence difficult, but GDM is thought to affect between 1% and 24% of pregnancies (<a href="./references#CD012048-bbs2-0020" title="FerraraA . Increasing prevalence of gestational diabetes mellitus. Diabetes Care2007;30(Suppl 2):S141‐S146. ">Ferrara 2007</a>). GDM can have significant adverse effects on the immediate and long‐term health of the mother and baby (<a href="./references#CD012048-bbs2-0040" title="The HAPO Study Cooperative Research Group. Hyperglycaemia and adverse pregnancy outcomes. New England Journal of Medicine2008;358(19):1991‐2002. ">The HAPO Study Cooperative Research Group 2008</a>; <a href="./references#CD012048-bbs2-0042" title="WangZ , KanguruL , HusseinJ , FitzmauriceA , RitchieK . Incidence of adverse outcomes associated with gestational diabetes mellitus in low‐ and middle‐income countries. International Journal of Gynecology and Obstetrics2013;121:14‐9. ">Wang 2013</a>; <a href="./references#CD012048-bbs2-0043" title="WendlandE , TorloniM , FalavignaM , TrujiloJ , DoseMA , CamposMA , et al. Gestational diabetes and pregnancy outcomes: a systematic review of the World Health Organization (WHO) and the International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy and Childbirth2012;12:23. ">Wendland 2012</a>), and the rising global incidence of GDM is exposing more women and infants to the increased risk of these short‐ and long‐term health complications (<a href="./references#CD012048-bbs2-0020" title="FerraraA . Increasing prevalence of gestational diabetes mellitus. Diabetes Care2007;30(Suppl 2):S141‐S146. ">Ferrara 2007</a>). </p> <div class="table" id="CD012048-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Diagnostic criteria for GDM</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Organisation</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Testing schedule</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Abnormal</b> </p> <p><b>values</b> </p> <p><b>required for diagnosis</b> </p> <p><b>of GDM</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Threshold equal to or greater than</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fasting</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 hour</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2 hours</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 hours</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australasian Diabetes in Pregnancy Society (<a href="./references#CD012048-bbs2-0032" title="NankervisA , McIntyreHD , MosesR , RossGP , CallawayL , PorterC , et al. for the Australasian Diabetes in Pregnancy Society (ADIPS). Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia. URL: http://adips.org/downloads/ADIPSConsensusGuidelinesGDM‐03.05.13VersionACCEPTEDFINAL.pdf (accessed 03 July 2015). ">Nankervis 2013</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>American Diabetes Association (<a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>American College of</p> <p>Obstetricians and Gynecologists* (<a href="./references#CD012048-bbs2-0006" title="American College of Obstetricians and Gynecologists. Gestational Diabetes Mellitus: Practice Bulletin Number 137. Obstetrics and Gynecology2013;122(2 Pt 1):406‐16. ">ACOG 2013</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either Carpenter &amp; Coustan</p> <p>100 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> <p>mmol/L</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>or NDDG</p> <p>100 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.2</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0</p> <p>mmol/L</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>International Association of Diabetes and Pregnancy Study Groups (<a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World Health Organization (<a href="./references#CD012048-bbs2-0008" title="AlbertiK , ZimmetP . Definition, diagnosis and classification of diabetes mellitus. Part 1: Diagnosis and classification of diabetes mellitus: World Health Organization Report. Diabetic Medicine1998;15(7):539‐53. ">Alberti 1998</a>) </p> <p>National Institute for Health and Care Excellence (<a href="./references#CD012048-bbs2-0035" title="National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre‐conception to the Postnatal Period. Manchester: NICE, 2015. ">NICE 2015</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1 mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canadian Diabetes Association (<a href="./references#CD012048-bbs2-0013" title="Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2008;32(Suppl 1):S1‐S201. ">CDA 2008</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.9</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand Ministry of Health (<a href="./references#CD012048-bbs2-0034" title="New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014. ">New Zealand Ministry of Health 2014</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>OGTT: oral glucose tolerance test</p> <p>* American College of Obstetricians and Gynecologists stipulates that either the Carpenter and Coustan or the National Diabetes Data Group (NDDG) thresholds are appropriate to use. </p> </div> </div> <p>Women with GDM are at greater risk of developing pre‐eclampsia and undergoing a caesarean section (<a href="./references#CD012048-bbs2-0009" title="AlwanN , TuffnellD , WestJ . Treatments for gestational diabetes. Cochrane Database of Systematic Reviews2009, Issue 3. [DOI: 10.1002/14651858.CD003395.pub2] ">Alwan 2009</a>), while long term, over half will go on to develop type 2 diabetes within 10 years (<a href="./references#CD012048-bbs2-0024" title="KimC , NewtonKM , KnoppRH . Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care2002;25:1862‐8. ">Kim 2002</a>). Infants of mothers with GDM can grow disproportionately large for their gestational age (<a href="./references#CD012048-bbs2-0012" title="CatalanoP , ThomasA , Huston‐PresleyL , AminiS . Increased fetal adiposity: a very sensitive marker of abnormal in utero development. American Journal of Obstetrics and Gynecology2003;189(6):1698‐704. ">Catalano 2003</a>). This in turn increases the likelihood of traumatic birth or shoulder dystocia (when the shoulders become stuck in the birth canal) leading to birth injuries such as bone fracture or nerve palsy (<a href="./references#CD012048-bbs2-0017" title="CrowtherC , HillerJ , MossJ , McPheeA , JeffriesW , RobinsonJ . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine2005;352:2477‐86. ">Crowther 2005</a>; <a href="./references#CD012048-bbs2-0025" title="LandonMB , SpongCY , ThomE , CarpenterMW , RaminSM , CaseyB , et al. A multicentre, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine2009;361(14):1339‐48. ">Landon 2009</a>). Additional risks for the immediate health of the infant include respiratory distress syndrome, jaundice, hypoglycaemia, and admission to the neonatal intensive care unit (<a href="./references#CD012048-bbs2-0017" title="CrowtherC , HillerJ , MossJ , McPheeA , JeffriesW , RobinsonJ . Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine2005;352:2477‐86. ">Crowther 2005</a>; <a href="./references#CD012048-bbs2-0025" title="LandonMB , SpongCY , ThomE , CarpenterMW , RaminSM , CaseyB , et al. A multicentre, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine2009;361(14):1339‐48. ">Landon 2009</a>). In the long term, babies born to mothers with GDM have a high likelihood of being obese as children and adults, and are at increased risk of metabolic syndrome and subsequently developing diabetes, perpetuating the cycle of poor health outcomes (<a href="./references#CD012048-bbs2-0010" title="BoneyCM , VermaA , TuckerR , VohrBR . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics2005;115(3):e290‐6. ">Boney 2005</a>; <a href="./references#CD012048-bbs2-0044" title="WestNA , CrumeTL , MaligieMA , DabeleaD . Cardiovascular risk factors in children exposed to maternal diabetes in utero. Diabetologia2011;54(3):504‐7. ">West 2011</a>). Identification of effective treatment measures for GDM is of great importance. </p> </section> <section id="CD012048-sec-0046"> <h3 class="title" id="CD012048-sec-0046">Description of the intervention</h3> <p>Both non‐pharmacological and pharmacological interventions are used to treat gestational diabetes. Currently, dietary and lifestyle counselling is the first line of treatment for women with GDM. Oral hypoglycaemics and/or insulin therapy are recommended for women with GDM who are unable to maintain glycaemic control with dietary and lifestyle interventions alone (<a href="./references#CD012048-bbs2-0030" title="MetzgerBE , CoustanDR . Proceedings of the Fourth International Workshop‐Conference on Gestational Diabetes Mellitus. Diabetes Care1998;21 (Suppl. 2):B1‐B167. ">Metzger 1998</a>; <a href="./references#CD012048-bbs2-0035" title="National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre‐conception to the Postnatal Period. Manchester: NICE, 2015. ">NICE 2015</a>; <a href="./references#CD012048-bbs2-0034" title="New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014. ">New Zealand Ministry of Health 2014</a>). </p> <p>Myo‐inositol has been identified as a potentially new and novel treatment for GDM (<a href="./references#CD012048-bbs2-0018" title="CrozeML , SoulageCO . Potential role and therapeutic interests of myo‐inositol in metabolic diseases. Biochimie2013;95(10):1811‐27. ">Croze 2013</a>). Myo‐inositol is one of the nine isomers (forms) of inositol, a simple carbohydrate and nutrient the body requires for many cell functions (<a href="./references#CD012048-bbs2-0018" title="CrozeML , SoulageCO . Potential role and therapeutic interests of myo‐inositol in metabolic diseases. Biochimie2013;95(10):1811‐27. ">Croze 2013</a>). Common dietary sources of inositol include fresh fruit and vegetables, cereals, legumes and nuts (<a href="./references#CD012048-bbs2-0014" title="ClementsRS , DarnellB . Myo‐inositol content of common foods: development of a high myo‐inositol diet. American Journal of Clinical Nutrition1980;33:1954‐67. ">Clements 1980</a>). Myo‐inositol is available as a dietary supplement, in water‐soluble powder form or as capsules. </p> <p>Myo‐inositol has been used therapeutically in a number of settings. In women with polycystic ovarian syndrome (PCOS), myo‐inositol supplementation has been associated with an improvement in insulin sensitivity, and ovulatory function (<a href="./references#CD012048-bbs2-0021" title="GenazzaniAD , LanzoniC , RicchieriF , JasonniVM . Myo‐inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovarian syndrome. Gynecological Endocrinology2008;24:139‐44. ">Genazzani 2008</a>; <a href="./references#CD012048-bbs2-0031" title="MinozziM , D'AndreaG , UnferV . Treatment of hirsutism with myo‐inositol: a prospective clinical study. Reproductive Biomedicine Online2008;17(4):579‐82. ">Minozzi 2008</a>; <a href="./references#CD012048-bbs2-0037" title="PapaleoE , UnferV , BaillargeonJP , DeSantisL , FusiF , BriganteC , et al. Myoinositol in patients with polycystic ovarian syndrome: a novel method for ovulation induction. Gynecological Endocrinology2007;23:700‐3. ">Papaleo 2007</a>). Myo‐inositol has been found to assist the normal production of thyroid hormone in patients with autoimmune thyroiditis (chronic inflammation of the thyroid gland) (<a href="./references#CD012048-bbs2-0036" title="NordioM , PajalichR . Combined treatment with Myo‐inositol and selenium ensures euthyroidism in subclinical hypothyroidism patients with autoimmune thyroiditis. Journal of Thyroid Research2013;2013:Article ID 424163. [DOI: 10.1155/2013/424163] ">Nordio 2013</a>), and is associated with successful treatment of premenstrual dysphoric disorder, a mood disorder disrupting the social and/or occupational life of affected women (<a href="./references#CD012048-bbs2-0011" title="CarlomagnoG , UnferV , BuffoS , D'AmbrosioF . Myo‐inositol in the treatment of premenstrual dysphoric disorder. Human Psychopharmacology: Clinical and Experimental2011;26(7):526‐30. ">Carlomagno 2011</a>). Increased numbers and quality of oocytes (immature eggs within the ovary) in women undergoing in vitro fertilisation treatment for a previous history of infertility have also been reported following myo‐inositol supplementation (<a href="./references#CD012048-bbs2-0041" title="UnferV , RaffoneE , RizzoP , BuffoS . Effect of a supplementation with myo‐inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecological Endocrinology2011;27:857‐61. ">Unfer 2011</a>). </p> <p>A retrospective review of 46 pregnant women treated with myo‐inositol compared to 37 controls, described myo‐inositol as safe during the pre‐pregnancy and early pregnancy period, when used in insulin‐resistant conditions, with no reported side effects (<a href="./references#CD012048-bbs2-0019" title="D'AnnaR , DiBendettoV , RizzoP , RaffoneE , InterdantoML , CoradoF , et al. Myo‐inositol may prevent gestational diabetes in PCOS women. Gynecological Endocrinology2012;28(6):440‐2. ">D'Anna 2012</a>). </p> </section> <section id="CD012048-sec-0047"> <h3 class="title" id="CD012048-sec-0047">How the intervention might work</h3> <p>The way insulin functions within the body is complex and still not fully understood (<a href="./references#CD012048-bbs2-0015" title="CohenP . The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology2006;7:867‐73. ">Cohen 2006</a>; <a href="./references#CD012048-bbs2-0018" title="CrozeML , SoulageCO . Potential role and therapeutic interests of myo‐inositol in metabolic diseases. Biochimie2013;95(10):1811‐27. ">Croze 2013</a>). Insulin has been shown to use second messengers to help transmit signals from insulin to its target cells. Second messengers increase the speed and strength of insulins message within its target cells (<a href="./references#CD012048-bbs2-0018" title="CrozeML , SoulageCO . Potential role and therapeutic interests of myo‐inositol in metabolic diseases. Biochimie2013;95(10):1811‐27. ">Croze 2013</a>). Myo‐inositol has been identified as a second messenger of insulin improving the body's sensitivity to the effects of insulin (<a href="./references#CD012048-bbs2-0026" title="LarnerJ , BrautiganDL , ThornerMO . D‐chiro‐inositol glycans in insulin signaling and insulin resistance. Molecular Medicine2010;16(11‐12):543‐51. ">Larner 2010</a>; <a href="./references#CD012048-bbs2-0039" title="SaltielAR . Second messengers of insulin action. Diabetes Care1990;13(3):244‐56. ">Saltiel 1990</a>). </p> </section> <section id="CD012048-sec-0048"> <h3 class="title" id="CD012048-sec-0048">Why it is important to do this review</h3> <p>A Cochrane systematic review has found some limited evidence to suggest that myo‐inositol may be effective at preventing the onset of GDM (<a href="./references#CD012048-bbs2-0016" title="CrawfordTJ , CrowtherCA , AlsweilerJ , BrownJ . Antenatal dietary supplementation with myo‐inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD011507.pub2] ">Crawford 2015</a>). Given the beneficial effects observed on insulin sensitivity, myo‐inositol may be useful as a treatment for women with gestational diabetes. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD012048-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD012048-sec-0049"></div> <p>To assess if dietary supplementation with myo‐inositol during pregnancy is safe and effective, for the mother and fetus, in treating gestational diabetes. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD012048-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD012048-sec-0050"></div> <section id="CD012048-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD012048-sec-0052"> <h4 class="title">Types of studies</h4> <p>All published and unpublished randomised controlled trials and cluster‐randomised trials, including conference abstracts, assessing the effects of myo‐inositol for the treatment of gestational diabetes mellitus (GDM). Quasi‐randomised trials and cross‐over trials are not eligible for inclusion in this review. </p> </section> <section id="CD012048-sec-0053"> <h4 class="title">Types of participants</h4> <p>Pregnant women with a diagnosis of GDM (as defined by trialists). Women with pre‐existing type 1 or type 2 diabetes were excluded. </p> </section> <section id="CD012048-sec-0054"> <h4 class="title">Types of interventions</h4> <p>The intervention includes administration of any dose of myo‐inositol, alone or in a combination preparation, after diagnosis of GDM in pregnancy, for the treatment of GDM. We included studies where the intervention is compared with those who received no treatment, placebo or another intervention. </p> </section> <section id="CD012048-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>This review uses a core set of outcomes developed through consensus by a group of authors who have written other Cochrane reviews on prevention of and treatments for women with GDM. This was done to improve consistency between reviews relating to women with GDM. </p> <section id="CD012048-sec-0056"> <h5 class="title">Primary outcomes</h5> <section id="CD012048-sec-0057"> <h6 class="title">Maternal outcomes</h6> <p> <ol id="CD012048-list-0001"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, eclampsia, pregnancy‐induced hypertension) </p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Development of subsequent type 2 diabetes mellitus (timeframe of long‐term follow‐up defined by trialists) </p> </li> </ol> </p> </section> <section id="CD012048-sec-0058"> <h6 class="title">Neonatal outcomes</h6> <p> <ol id="CD012048-list-0002"> <li> <p>Large‐for‐gestational age (birthweight greater than the 90th centile; or as defined by individual trials) </p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Mortality or morbidity composite (variously defined by trials, e.g. infant death, shoulder dystocia, bone fracture or nerve palsy) </p> </li> <li> <p>Neurosensory disability</p> </li> </ol> </p> </section> </section> <section id="CD012048-sec-0059"> <h5 class="title">Secondary outcomes</h5> <section id="CD012048-sec-0060"> <h6 class="title">Maternal outcomes</h6> <p> <ol id="CD012048-list-0003"> <li> <p>Induction of labour</p> </li> <li> <p>Perineal trauma</p> </li> <li> <p>Placental abruption</p> </li> <li> <p>Postpartum haemorrhage</p> </li> <li> <p>Postpartum infection</p> </li> <li> <p>Weight gain during pregnancy</p> </li> <li> <p>Adherence to the intervention (as defined by trialists)</p> </li> <li> <p>Behaviour changes associated with the intervention (as defined by trialists)</p> </li> <li> <p>Relevant biomarker changes associated with the intervention (e.g. adiponectin, free fatty acids, triglycerides, high‐density lipoproteins, low‐density lipoproteins, insulin) </p> </li> <li> <p>Breastfeeding (e.g. at discharge, six weeks postpartum)</p> </li> <li> <p>Use of additional pharmacotherapy</p> </li> <li> <p>Glycaemic control during/end of treatment (as defined by trialists)</p> </li> <li> <p>Maternal hypoglycaemia</p> </li> <li> <p>Maternal mortality</p> </li> <li> <p>Sense of well‐being and quality of life</p> </li> <li> <p>Views of the intervention</p> </li> </ol> </p> </section> <section id="CD012048-sec-0061"> <h6 class="title">Long‐term maternal outcomes</h6> <p> <ol id="CD012048-list-0004"> <li> <p>Postnatal depression</p> </li> <li> <p>Postnatal weight retention or return to pre‐pregnancy weight</p> </li> <li> <p>Body mass index (BMI)</p> </li> <li> <p>GDM in a subsequent pregnancy</p> </li> <li> <p>Type 1 diabetes mellitus</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> </ol> </p> </section> <section id="CD012048-sec-0062"> <h6 class="title">Neonatal/Infant outcomes</h6> <p> <ol id="CD012048-list-0005"> <li> <p>Stillbirth</p> </li> <li> <p>Neonatal mortality</p> </li> <li> <p>Gestational age at birth</p> </li> <li> <p>Preterm birth (less than 37 weeks' gestation and less than 32 weeks' gestation)</p> </li> <li> <p>Apgar score (less than seven at five minutes)</p> </li> <li> <p>Macrosomia</p> </li> <li> <p>Small‐for‐gestational age</p> </li> <li> <p>Birthweight and z‐score</p> </li> <li> <p>Head circumference and z‐score</p> </li> <li> <p>Length and z‐score</p> </li> <li> <p>Ponderal index</p> </li> <li> <p>Adiposity (as defined by trialists)</p> </li> <li> <p>Shoulder dystocia</p> </li> <li> <p>Bone fracture</p> </li> <li> <p>Nerve palsy</p> </li> <li> <p>Respiratory distress syndrome</p> </li> <li> <p>Hypoglycaemia (as defined by trialists)</p> </li> <li> <p>Hyperbilirubinaemia</p> </li> <li> <p>Neonatal hypocalcaemia</p> </li> <li> <p>Polycythaemia (increase in the number of red blood cells)</p> </li> <li> <p>Relevant biomarker changes associated with the intervention (e.g. cord C‐peptide, cord insulin) </p> </li> </ol> </p> </section> <section id="CD012048-sec-0063"> <h6 class="title">Later childhood outcomes</h6> <p> <ol id="CD012048-list-0006"> <li> <p>Weight and z‐scores</p> </li> <li> <p>Height and z‐scores</p> </li> <li> <p>Head circumference and z‐scores</p> </li> <li> <p>Adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Blood pressure</p> </li> <li> <p>Type 1 diabetes mellitus</p> </li> <li> <p>Type 2 diabetes mellitus</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Dyslipidaemia or metabolic syndrome</p> </li> <li> <p>Educational achievement</p> </li> </ol> </p> </section> <section id="CD012048-sec-0064"> <h6 class="title">Adulthood outcomes</h6> <p> <ol id="CD012048-list-0007"> <li> <p>Weight</p> </li> <li> <p>Height</p> </li> <li> <p>Adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Cardiovascular health (as defined by trialists, including blood pressure, hypertension, cardiovascular disease, metabolic syndrome) </p> </li> <li> <p>Type 1 diabetes mellitus</p> </li> <li> <p>Type 2 diabetes mellitus</p> </li> <li> <p>Impaired glucose tolerance</p> </li> <li> <p>Dyslipidaemia or metabolic syndrome</p> </li> <li> <p>Employment, education and social status/achievement</p> </li> </ol> </p> </section> <section id="CD012048-sec-0065"> <h6 class="title">Health services cost</h6> <p> <ol id="CD012048-list-0008"> <li> <p>Number of hospital or health professional visits (e.g. midwife, obstetrician, physician, dietitian, diabetic nurse) </p> </li> <li> <p>Number of antenatal visits or admissions</p> </li> <li> <p>Length of antenatal stay</p> </li> <li> <p>Neonatal intensive care unit admission</p> </li> <li> <p>Length of postnatal stay (mother)</p> </li> <li> <p>Length of postnatal stay (baby)</p> </li> <li> <p>Costs to families associated with the management provided</p> </li> <li> <p>Costs associated with the intervention (as defined by trialists)</p> </li> <li> <p>Cost of maternal care</p> </li> <li> <p>Cost of offspring care</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD012048-sec-0066"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirth Group. </p> <section id="CD012048-sec-0067"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register by contacting their Information Specialist (30 April 2016)<b>.</b> </p> <p>The Register is a database containing over 22,000 reports of controlled trials in the field of pregnancy and childbirth. For the full search methods used to populate the Pregnancy and Childbirth Group’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this link to the editorial information about the <a href="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html" target="_blank">Cochrane Pregnancy and Childbirth Group</a> in the Cochrane Library and select the ‘<i><b>Specialized Register</b> </i> ’ section from the options on the left side of the screen. </p> <p>Briefly, the Cochrane Pregnancy and Childbirth Group’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD012048-list-0009"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth Group review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set which has been fully accounted for in the relevant review sections (<a href="./references#CD012048-bbs1-0001" title="">Included studies</a>; <a href="./references#CD012048-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD012048-bbs1-0003" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) for unpublished, planned and ongoing trial reports (see <a href="./appendices#CD012048-sec-0138">Appendix 1</a> for search terms) (searched 7 April 2016). </p> </section> <section id="CD012048-sec-0068"> <h4 class="title">Searching other resources</h4> <p>We searched reference lists of retrieved studies. We did not apply any language or date restrictions. </p> </section> </section> <section id="CD012048-sec-0069"> <h3 class="title" id="CD012048-sec-0069">Data collection and analysis</h3> <section id="CD012048-sec-0070"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy (JB, TC). There were no disagreements. A study flow diagram was produced to map out the number of records identified, included and excluded (<a href="#CD012048-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD012048-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD012048-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD012048-sec-0071"> <h4 class="title">Data extraction and management</h4> <p>We designed a form to extract data based on the Cochrane Pregnancy and Childbirth Group's data extraction form. For eligible studies, two review authors extracted the data (JB, TC or JA) using the agreed form. There were no discrepancies that needed to be resolved. We entered data into Review Manager software (<a href="./references#CD012048-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) and checked for accuracy. Where information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD012048-sec-0072"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias (JB, TC or JA) for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD012048-bbs2-0022" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). We did not have any disagreements that required discussion with a third author. </p> <section id="CD012048-sec-0073"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD012048-list-0010"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0074"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD012048-list-0011"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes, alternation; date of birth); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0075"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD012048-list-0012"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0076"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods used to blind outcome assessment as:</p> <p> <ul id="CD012048-list-0013"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0077"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include any missing data in the analyses. </p> <p>We assessed methods as:</p> <p> <ul id="CD012048-list-0014"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0078"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD012048-list-0015"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest were reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0079"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we have about other possible sources of bias. </p> <p>We assessed whether each study was free of other problems that could put it at risk of bias: </p> <p> <ul id="CD012048-list-0016"> <li> <p>low risk of other bias;</p> </li> <li> <p>high risk of other bias;</p> </li> <li> <p>unclear whether there is risk of other bias.</p> </li> </ul> </p> </section> <section id="CD012048-sec-0080"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD012048-bbs2-0022" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We planned to explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD012048-sec-0098">Sensitivity analysis</a>. </p> </section> <section id="CD012048-sec-0081"> <h5 class="title">Assessing the quality of the body of evidence using the GRADE approach</h5> <p>The quality of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the following outcomes. We selected up to a maximum of seven outcomes for the mother and seven for the infant covering both short‐ and long‐term outcomes for the main comparisons. </p> <section id="CD012048-sec-0082"> <h6 class="title">Maternal</h6> <p> <ol id="CD012048-list-0017"> <li> <p>Hypertensive disorders of pregnancy (including pre‐eclampsia, eclampsia, pregnancy‐induced hypertension) </p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Induction of labour</p> </li> <li> <p>Perineal trauma</p> </li> <li> <p>Postnatal weight retention or return to pre‐pregnancy weight</p> </li> <li> <p>Postnatal depression</p> </li> <li> <p>Development of subsequent type 2 diabetes mellitus</p> </li> </ol> </p> </section> <section id="CD012048-sec-0083"> <h6 class="title">Offspring (infant, child, adult)</h6> <p> <ol id="CD012048-list-0018"> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Composite of serious neonatal outcomes</p> </li> <li> <p>Neonatal hypoglycaemia (variously defined)</p> </li> <li> <p>Offspring adiposity (e.g. as measured by BMI, skinfold thickness)</p> </li> <li> <p>Offspring diabetes</p> </li> <li> <p>Neurosensory disability</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD012048-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create 'Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes will be produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> </section> <section id="CD012048-sec-0084"> <h4 class="title">Measures of treatment effect</h4> <section id="CD012048-sec-0085"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we have presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD012048-sec-0086"> <h5 class="title">Continuous data</h5> <p>For continuous data, we used the mean difference with 95% confidence intervals if outcomes were measured in the same way between trials. </p> </section> </section> <section id="CD012048-sec-0087"> <h4 class="title">Unit of analysis issues</h4> <section id="CD012048-sec-0088"> <h5 class="title">Cluster‐randomised trials</h5> <p>We did not identify any cluster‐randomised trials. In future updates of this review where cluster‐randomised trials are identified, they will be included in the analyses along with individually‐randomised trials. We will make adjustments using the methods described in the <i>Handbook</i> [Section 16.3.4 or 16.3.6] (<a href="./references#CD012048-bbs2-0022" title="HigginsJPT , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we use ICCs from other sources, we will report this and conduct sensitivity analyses to investigate the effect of variation in the ICC. We will consider it reasonable to combine the results from both cluster‐randomised trials and individually‐randomised trials if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. </p> </section> <section id="CD012048-sec-0089"> <h5 class="title">Multiple pregnancy</h5> <p>None of the included trials included women with a multiple pregnancy. We acknowledge that there may be unit of analysis issues that arise when the women randomised have a multiple pregnancy. In future updates of this review, if trials with multiple pregnancies are included, we will present maternal data as per woman randomised and neonatal data per infant. </p> </section> <section id="CD012048-sec-0090"> <h5 class="title">Multiple‐arm studies</h5> <p>No multiple arm trials were identified. In future updates, where a trial has multiple intervention arms we will avoid 'double counting' of participants by combining groups to create a single pair‐wise comparison, if possible. Where this is not possible, we will split the 'shared' group into two or more groups with smaller sample size and include two or more (reasonably independent) comparisons. </p> </section> </section> <section id="CD012048-sec-0091"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. There were no trials with more than 20% attrition. In future updates of this review, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, we carried out analyses, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD012048-sec-0092"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either a Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </p> </section> <section id="CD012048-sec-0093"> <h4 class="title">Assessment of reporting biases</h4> <p>Only two trials were included in the meta‐analysis. If in future updates there are 10 or more studies included in the meta‐analysis, we will investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it. </p> </section> <section id="CD012048-sec-0094"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using Review Manager software (<a href="./references#CD012048-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies are estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. Where there was clinical heterogeneity sufficient to expect that the underlying treatment effects differ between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average of the range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. </p> <p>Where we use random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD012048-sec-0095"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>There were insufficient trials to be able to explore subgroup analyses. In future updates, if there are sufficient data and if we identify substantial heterogeneity, we will investigate it using subgroup analyses and sensitivity analyses. We will consider whether an overall summary is meaningful, and if it is, use random‐effects analysis to produce it. </p> <p>We plan to carry out the following subgroup analyses.</p> <p> <ol id="CD012048-list-0019"> <li> <p>Obese women versus non‐obese women</p> </li> <li> <p>Polycystic ovary syndrome (PCOS) women versus non‐PCOS women</p> </li> <li> <p>Myo‐inositol alone versus as a co‐intervention</p> </li> <li> <p>Dosage (high versus low)</p> </li> <li> <p>Type of preparation (e.g. powder versus gel capsules)</p> </li> <li> <p>Study design (individually‐randomised trials versus cluster‐randomised trials, if cluster‐randomised trials are identified) </p> </li> </ol> </p> <p>The following primary outcomes will be used in subgroup analysis.</p> <section id="CD012048-sec-0096"> <h5 class="title">Maternal outcomes</h5> <p> <ol id="CD012048-list-0020"> <li> <p>Hypertensive disorders of pregnancy (e.g. pre‐eclampsia, eclampsia, pregnancy‐induced hypertension) </p> </li> <li> <p>Caesarean section</p> </li> <li> <p>Development of subsequent type 2 diabetes mellitus</p> </li> </ol> </p> </section> <section id="CD012048-sec-0097"> <h5 class="title">Neonatal outcomes</h5> <p> <ol id="CD012048-list-0021"> <li> <p>Large‐for‐gestational age</p> </li> <li> <p>Perinatal mortality (stillbirth and neonatal mortality)</p> </li> <li> <p>Composite of serious neonatal outcomes</p> </li> <li> <p>Neurosensory disability</p> </li> </ol> </p> <p>In future updates of this review, we will assess subgroup differences, where appropriate, by interaction tests available within RevMan (<a href="./references#CD012048-bbs2-0038" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We will report the results of subgroup analyses quoting the Chi<sup>2</sup> statistic and P value, and the interaction test I² value. </p> </section> </section> <section id="CD012048-sec-0098"> <h4 class="title">Sensitivity analysis</h4> <p>Planned sensitivity analysis was not carried out due to insufficient data. In future updates of this review, where there is evidence of significant heterogeneity, we will explore this by using the quality of the included trials for the primary outcomes. Trials that have a low risk of bias for allocation concealment will be compared with those judged to be of unclear or high risk of bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD012048-sec-0099" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD012048-sec-0099"></div> <section id="CD012048-sec-0100"> <h3 class="title">Description of studies</h3> <section id="CD012048-sec-0101"> <h4 class="title">Results of the search</h4> <p>See: (<a href="#CD012048-fig-0001">Figure 1</a>). </p> <p>The search retrieved eight relevant reports of five studies.</p> <p>Two studies met the inclusion criteria for this review (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) (See <a href="./references#CD012048-sec-0146" title="">Characteristics of included studies</a>). Two studies were excluded (<a href="./references#CD012048-bbs2-0003" title="MalvasiA , CasciaroF , MinerviniMM , KosmasI , MynbaevOA , PacellaE , et al. Myo‐inositol, D‐chiro‐inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. European Review for Medical and Pharmacological Sciences2014;18(2):270‐4. ">Malvasi 2014</a>; <a href="./references#CD012048-bbs2-0004" title="NCT02149992 . Glycaemic impact of myo‐inositol in pregnancy. clinicaltrials.gov/show/NCT02149992 Date first received: 25 May 2014. ">Valent 2014</a>) (See <a href="./references#CD012048-sec-0147" title="">Characteristics of excluded studies</a>). One ongoing study was identified (<a href="./references#CD012048-bbs2-0005" title="NCT02097069 . Inositol stereoisomers to treat gestational diabetes. clinicaltrials.gov/show/NCT02097069 Date first received: 27 February 2014. ">Vitacolonna 2014</a>) (See <a href="./references#CD012048-sec-0148" title="">Characteristics of ongoing studies</a>). This four‐arm study plans to recruit 80 pregnant women with gestational diabetes. The interventions include myo‐inositol 2000 mg twice a day; d‐chiro‐inositol 250 mg twice a day; myo‐inositol 550 mg plus d‐chiro‐inositol 13.8 mg twice a day and the control group will receive folic acid 400 mcg/day. In subsequent updates of this review we will look to see if data have been published that relate to this trial. </p> </section> <section id="CD012048-sec-0102"> <h4 class="title">Included studies</h4> <p>Two trials met the eligibility criteria for inclusion in this review (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) (See <a href="./references#CD012048-sec-0146" title="">Characteristics of included studies</a>). Both trials were individually‐randomised controlled trials including a total of 142 women. <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> randomised 84 women and included 69 in the final analysis. <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> randomised 75 women, 73 of whom were included in the final analysis. </p> <section id="CD012048-sec-0103"> <h5 class="title">Population</h5> <p>All participants were pregnant women recruited between 2008 and 2011. Diagnosis of gestational diabetes mellitus (GDM) was between 24 and 28 weeks by American Diabetes Association criteria (<a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>) in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>, or in the first or early second trimester by International Association of Diabetes and Pregnancy Study Groups criteria (<a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>) in <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> (<a href="#CD012048-tbl-0004">Table 2</a>). All the participants in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> were reported to be "Caucasian". The ethnicity of the participants in <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> was not reported. The women in <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> had a slightly higher mean age (mean age 33.0 years intervention group; 33.8 years control group), compared to the women in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> (mean age 28.7 years intervention group; 28.4 years control group). Primiparious and multiparous women were included in both trials with approximately even proportions of both. Pre‐pregnancy BMI was similar between groups in both trials (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> mean BMI intervention group 25.1 kg/m<sup>2</sup>; 24.2 kg/m<sup>2</sup> control group; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> mean BMI 23.5 mg/kg<sup>2</sup> intervention group; 24.7 mg/kg<sup>2</sup> control group). An exclusion criteria of <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> was BMI greater than 35 mg/kg<sup>2</sup>. Both trials used <a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a> treatment targets, reported in <a href="#CD012048-tbl-0005">Table 3</a>. </p> <div class="table" id="CD012048-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Diagnostic criteria used in included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study ID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Criteria</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 to 28 weeks'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 abnormal plasma glucose values following</p> <p>100 g OGTT</p> <p>Fasting: ≥ 5.3 mmol/L (≥ 95 mg/dL)</p> <p>1 hour: ≥ 10.0 mmol/L (≥ 180 mg/dL)</p> <p>2 hour: ≥ 8.6 mmol/L (≥ 155 mg/dL)</p> <p>3 hour: ≥ 7.8 mmol/L (≥ 140 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(<a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 to 28 weeks'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One or more abnormal blood glucose values following</p> <p>75 g OGTT</p> <p>Fasting: &gt; 5.1 mmol/L (&gt; 92 mg/dL)</p> <p>1 hour: &gt; 10.0 mmol/L (&gt; 180 mg/dL)</p> <p>2 hour: &gt; 8.5 mmol/L (&gt; 153 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(<a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>) </p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD012048-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">ADA 2008 Treatment targets used in included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fasting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1‐hour post‐prandial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2‐hour post‐prandial</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 5.8 mmol/L (&lt; 105 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either</p> <p>&lt; 8.6 mmol/L (&lt; 155 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Or</p> <p>&lt; 7.2 mmol/L (&lt; 130 mg/dL)</p> </td> </tr> </tbody> </table> </div> </section> <section id="CD012048-sec-0104"> <h5 class="title">Setting</h5> <p>Both trials were conducted in Obstetric and Gynecology Departments of University Hospitals in two regions of Southern Italy. </p> </section> <section id="CD012048-sec-0105"> <h5 class="title">Intervention</h5> <p>Each of the trials used a total of 4000 mg myo‐inositol plus 400 mcg folic acid per day in divided doses as the intervention, and 400 mcg of folic acid as the placebo. Women were supplemented for eight weeks in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>. The duration of supplementation was not stated in <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>. </p> </section> <section id="CD012048-sec-0106"> <h5 class="title">Outcomes</h5> <p>The outcomes of this review were poorly reported in the two included trials. None of the maternal primary outcomes of this review were reported (hypertensive disorders of pregnancy; development of subsequent type 2 diabetes mellitus). For the infant, large‐for‐gestational age was reported in one trial (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). None of the other primary infant outcomes for this review were reported in the included trials (perinatal mortality; mortality or morbidity composite; neurosensory disability). </p> <p>For maternal secondary outcomes, only weight gain during pregnancy (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>), BMI increase (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>), need for insulin therapy (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) and glycaemic control (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) were reported. None of the other pre‐specified maternal outcomes or long‐term maternal outcomes were reported in the included trials. For neonatal secondary outcomes, only gestational age at birth (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>), preterm birth (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>), birthweight (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) and neonatal hypoglycaemia (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) were reported. None of the other pre‐specified neonatal outcomes or long‐term outcomes for childhood or adulthood were reported in the included trials. </p> </section> </section> <section id="CD012048-sec-0107"> <h4 class="title">Excluded studies</h4> <p>Two trials identified in the search were excluded from this review (<a href="./references#CD012048-bbs2-0003" title="MalvasiA , CasciaroF , MinerviniMM , KosmasI , MynbaevOA , PacellaE , et al. Myo‐inositol, D‐chiro‐inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. European Review for Medical and Pharmacological Sciences2014;18(2):270‐4. ">Malvasi 2014</a>; <a href="./references#CD012048-bbs2-0004" title="NCT02149992 . Glycaemic impact of myo‐inositol in pregnancy. clinicaltrials.gov/show/NCT02149992 Date first received: 25 May 2014. ">Valent 2014</a>). </p> <p><a href="./references#CD012048-bbs2-0003" title="MalvasiA , CasciaroF , MinerviniMM , KosmasI , MynbaevOA , PacellaE , et al. Myo‐inositol, D‐chiro‐inositol, folic acid and manganese in second trimester of pregnancy: a preliminary investigation. European Review for Medical and Pharmacological Sciences2014;18(2):270‐4. ">Malvasi 2014</a> assessed the use of myo‐inositol supplementation in preventing the onset of GDM and is included in the Cochrane review '<i>Antenatal dietary supplementation with myo‐inositol in women during pregnancy for preventing gestational diabetes</i>' (<a href="./references#CD012048-bbs2-0016" title="CrawfordTJ , CrowtherCA , AlsweilerJ , BrownJ . Antenatal dietary supplementation with myo‐inositol in women during pregnancy for preventing gestational diabetes. Cochrane Database of Systematic Reviews2015, Issue 12. [DOI: 10.1002/14651858.CD011507.pub2] ">Crawford 2015</a>). <a href="./references#CD012048-bbs2-0004" title="NCT02149992 . Glycaemic impact of myo‐inositol in pregnancy. clinicaltrials.gov/show/NCT02149992 Date first received: 25 May 2014. ">Valent 2014</a> is a trial registration of a prospective cohort pilot study examining the pharmaco‐dynamics of myo‐inositol in pregnancy. </p> </section> </section> <section id="CD012048-sec-0108"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD012048-fig-0002">Figure 2</a>; <a href="#CD012048-fig-0003">Figure 3</a> for a summary of the risk of bias of included studies. </p> <div class="figure" id="CD012048-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012048-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD012048-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012048-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD012048-sec-0109"> <h4 class="title">Allocation</h4> <p>Both trials (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) used computer‐generated randomisation and were judged to be at low risk of selection bias. <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> used a central pharmacy to prepare identical looking sealed sachets, numbered according to the computer‐generated randomisation scheme. This was judged to be at low risk of bias for allocation concealment. No details of allocation concealment method were provided in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>, and the risk of bias was judged to be unclear. </p> </section> <section id="CD012048-sec-0110"> <h4 class="title">Blinding</h4> <p><a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> described blinding of participants and the healthcare providers caring for them and was judged to be at low risk of performance bias. Blinding was not undertaken in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> as this was an open‐label trial. It was assessed as having an unclear risk of performance bias. </p> <p>Neither trial provided sufficient detail on blinding of outcome assessors and were both judged to have an unclear risk of detection bias. However, in <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> the primary outcome was objective measurement of laboratory results which would not be influenced by knowledge of group allocation. </p> </section> <section id="CD012048-sec-0111"> <h4 class="title">Incomplete outcome data</h4> <p><a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> randomised 84 women but analysis was conducted on only 69 women (four from the study group and 11 in the control group were excluded post randomisation). This was assessed as having an unclear risk of attrition bias. One woman from each group withdrew from <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> (reason not provided) was judged to have a low risk of attrition bias. </p> </section> <section id="CD012048-sec-0112"> <h4 class="title">Selective reporting</h4> <p><a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> was judged to be of high risk of reporting bias as although the pre‐specified maternal outcomes are reported, there are no other pregnancy or birth outcomes specified or reported. No neonatal outcomes are reported despite birthweight being listed in the protocol on ClinicalTrials.gov (NCT0073448). </p> <p><a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> was judged to be of unclear risk of bias. They reported on their pre‐specified maternal and infant outcomes. Neonatal hypoglycaemia was not a pre‐specified outcome, but results were provided. </p> </section> <section id="CD012048-sec-0113"> <h4 class="title">Other potential sources of bias</h4> <p>Both <a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> and <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> were judged to be of low risk for other sources of bias and baseline characteristics were reported to be similar between intervention and control groups. </p> </section> </section> <section id="CD012048-sec-0114"> <h3 class="title" id="CD012048-sec-0114">Effects of interventions</h3> <p>See: <a href="./full#CD012048-tbl-0001"><b>Summary of findings for the main comparison</b> Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</a>; <a href="./full#CD012048-tbl-0002"><b>Summary of findings 2</b> Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</a> </p> <section id="CD012048-sec-0115"> <h4 class="title">1.0 Myo‐inositol versus placebo</h4> <section id="CD012048-sec-0116"> <h5 class="title">Primary outcomes</h5> <section id="CD012048-sec-0117"> <h6 class="title">Maternal outcomes</h6> <p>None of the maternal primary outcomes of this review were reported in the two included trials (<b>hypertensive disorders of pregnancy; caesarean section; development of subsequent type 2 diabetes mellitus</b>). </p> </section> <section id="CD012048-sec-0118"> <h6 class="title">Neonatal outcomes</h6> <p><b>Large‐for‐gestational age</b> was reported in one trial (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). There were no events recorded in the 35 infants in the myo‐inositol group and one event of the 38 infants in the control group. There was no clear evidence of a difference in the risk for being born large‐for‐gestational age between the myo‐inositol and the control group (risk ratio (RR) 0.36; 95% confidence interval (CI) 0.02 to 8.58; one trial, n = 73 infants; <a href="./references#CD012048-fig-0004" title="">Analysis 1.1</a>). There is evidence of imprecision with wide CIs, small sample size and low event rates. Using GRADE methodology, we judged this to be<i>low‐quality evidence</i> due to imprecision. For infants whose mothers had been in the placebo group, the chance of being born large‐for‐gestational age was 3%; if the mother was in the myo‐inositol group, the chance could have ranged from 0% to 23% (<a href="./full#CD012048-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>No data were reported for the other primary neonatal outcomes of this review (<b>perinatal mortality; mortality or morbidity composite; neurosensory disability</b>). </p> </section> </section> <section id="CD012048-sec-0119"> <h5 class="title">Secondary outcomes</h5> <section id="CD012048-sec-0120"> <h6 class="title">Maternal outcomes</h6> <p><i>Weight gain during pregnancy</i> was reported in one trial (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>), and one trial reported on BMI change during pregnancy (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). There was no clear evidence of a difference in weight gain during pregnancy between the myo‐inositol and the control group (mean difference (MD) ‐0.50 kg; 95% CI ‐3.25 to 2.25; one trial, n = 69 women; <a href="./references#CD012048-fig-0005" title="">Analysis 1.2</a>). There is evidence of imprecision with wide CIs and small sample size. The <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> trial reported that myo‐inositol was associated with a reduction in BMI during pregnancy compared with the control group (MD ‐1.50 kg/m<sup>2</sup>; 95% CI ‐2.35 to ‐0.65; one trial, n = 73 women; <a href="./references#CD012048-fig-0006" title="">Analysis 1.3</a>). </p> <p><i>Use of additional pharmacotherapy</i> was reported in both of the included studies (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). There was no clear evidence of a difference in the need for supplementary insulin between the myo‐inositol (4/63) and the control group (17/94) (average RR 0.37; 95% CI 0.08 to 1.73; two trials, n = 157 women; random‐effects I<sup>2</sup> = 45%, Tau<sup>2</sup> = 0.61; <a href="./references#CD012048-fig-0007" title="">Analysis 1.4</a>). There is evidence of imprecision with wide CIs, small sample size and low event rates. </p> <p><i>Glycaemic control during/end of treatment.</i> Both trials (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>; <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>) reported on fasting blood glucose concentrations at the end of treatment. Myo‐inositol treatment was associated a reduction in fasting blood glucose concentration at the end of treatment (MD ‐0.47 mmol/L; 95% CI ‐0.59 to ‐0.35; two trials, n = 142 women; <a href="./references#CD012048-fig-0008" title="">Analysis 1.5</a>) compared with the control group. The <a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> trial reported that myo‐inositol was associated with a reduction in one‐hour post‐prandial blood glucose concentrations at the end of treatment (MD ‐0.90 mmol/L; 95% CI ‐1.73 to ‐0.07; one trial, n = 73 women; <a href="./references#CD012048-fig-0009" title="">Analysis 1.6</a>) compared with the control group. There was no clear difference between groups for two‐hour post‐prandial blood glucose concentrations, although the same trend towards reduced blood glucose concentrations is observed in the myo‐inositol group (MD ‐0.70 mmol/L; 95% CI ‐1.46 to 0.06; one trial, n = 73 women; <a href="./references#CD012048-fig-0010" title="">Analysis 1.7</a>). The one‐hour and two‐hour blood glucose concentrations show evidence of imprecision associated with wide CIs and small sample size. </p> <p>No data were reported for any of the other maternal secondary outcomes of this review (<i>placental abruption; induction of labour; perineal trauma; postpartum haemorrhage; postpartum infection; adherence to the intervention; behaviour changes associated with the intervention; relevant biomarker changes associated with the intervention; sense of well‐being and quality of life; views of the intervention; breastfeeding; maternal hypoglycaemia; maternal mortality</i>). </p> </section> <section id="CD012048-sec-0121"> <h6 class="title">Long‐term maternal outcomes</h6> <p>No data were reported for any of the long‐term maternal outcomes pre‐specified in this review (<i>postnatal depression; postnatal weight retention or return to pre‐pregnancy weight; body mass index; GDM in a subsequent pregnancy; type I diabetes mellitus; impaired glucose tolerance; cardiovascular health (as defined by trialists</i>). </p> </section> <section id="CD012048-sec-0122"> <h6 class="title">Neonatal outcomes</h6> <p><i>Gestational age at birth</i> was reported in one study (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). Treatment with myo‐inositol was associated with being born at a later gestational age than the placebo group (MD 2.10 weeks; 95% CI 1.27 to 2.93; one trial, n = 73 infants; <a href="./references#CD012048-fig-0011" title="">Analysis 1.8</a>). </p> <p><i>Preterm birth</i> was reported in one study (<a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a>). There was no evidence of a clear difference between groups for the risk of preterm birth (&lt; 37 weeks) (RR 1.00; 95% CI 0.09 to 10.56; one study, n = 84 infants; <a href="./references#CD012048-fig-0012" title="">Analysis 1.9</a>). Caution is advised in interpreting these results due to imprecision with low event rates, small sample size and wide CIs crossing the line of no effect being observed. </p> <p><i>Birthweight</i> was reported in one study (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). There was no evidence of a clear difference between the myo‐inositol and the placebo groups for birthweight (MD 16.00 g; 95% CI ‐209.72 to 241.72; one study, n = 73 infants; <a href="./references#CD012048-fig-0013" title="">Analysis 1.10</a>). There is evidence of imprecision with wide CIs crossing the line of no effect. </p> <p><i>Neonatal hypoglycaemia</i> was reported in one study (<a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a>). Maternal treatment with myo‐inositol was associated with a reduced risk of neonatal hypoglycaemia compared with placebo (RR 0.05; 95% CI 0.00 to 0.85; one study, n = 73 infants; <a href="./references#CD012048-fig-0014" title="">Analysis 1.11</a>). There is evidence of imprecision for this outcome with low event rates and small sample size. Using GRADE methodology, we judged this to be <i>low‐quality evidence</i> due to imprecision. For infants whose mothers were in the placebo group, the chance of neonatal hypoglycaemia was 26%; if the infants' mothers had been in the myo‐inositol group, the chance would have ranged from 0% to 22%. </p> <p>No data were reported for any of the other neonatal secondary outcomes of this review (<i>stillbirth; neonatal mortality; Apgar score (less than seven at five minutes); macrosomia; small‐for‐gestational age; birthweight z‐score; head circumference and z‐score; length and z‐score; ponderal index; adiposity; shoulder dystocia; bone fracture; nerve palsy; respiratory distress syndrome; hyperbilirubinaemia; neonatal hypocalcaemia; polycythaemia; relevant biomarker changes associated with the intervention</i>. </p> </section> <section id="CD012048-sec-0123"> <h6 class="title">Later childhood outcomes</h6> <p>No data were reported for any of the long‐term outcomes of the neonate as a child for this review (<i>weight and z‐scores; height and z‐scores; head circumference and z‐scores; adiposity; blood pressure; type I or type 2 diabetes mellitus; impaired glucose tolerance; dyslipidaemia or metabolic syndrome; educational achievement</i>). </p> </section> <section id="CD012048-sec-0124"> <h6 class="title">Adulthood outcomes</h6> <p>No data were reported for any of the long‐term outcomes of the neonate as an adult for this review (<i>weight; height; adiposity; cardiovascular health; type I or type 2 diabetes mellitus; impaired glucose tolerance; dyslipidaemia or metabolic syndrome; employment, education and social status/achievement</i>). </p> </section> <section id="CD012048-sec-0125"> <h6 class="title">Health service outcomes</h6> <p>No data were reported for any of the health service outcomes pre‐specified for this review (<i>number of hospital or health professional visits; number of antenatal visits or admissions; length of antenatal stay; neonatal intensive care unit admission; length of postnatal stay (mother); length of postnatal stay (baby); costs to families associated with the management provided; costs associated with the intervention; cost of maternal care; cost of offspring care</i>). </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD012048-sec-0126" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD012048-sec-0126"></div> <section id="CD012048-sec-0127"> <h3 class="title" id="CD012048-sec-0127">Summary of main results</h3> <p>This review includes two small trials (involving 142 women and their babies).</p> <p>None of the maternal primary outcomes for this review were reported in the included studies. There was no clear evidence for a difference between those receiving myo‐inositol and those receiving placebo for weight gain during pregnancy or for the need for additional pharmacological therapy. There was limited evidence from two trials (142 women) that suggested that myo‐inositol was associated with a reduced fasting blood glucose concentration compared to placebo. There was no evidence of a difference between groups for the two‐hour postprandial blood glucose concentration in one study of 73 women. The clinical significance of the maternal blood glucose outcomes is not clear. No other maternal outcomes for this review were reported. </p> <p>For the infant, there was no evidence of a difference between myo‐inositol and placebo groups for the risk of being born large‐for‐gestational age. None of the other infant primary outcomes were reported in the included studies. There was no evidence of a difference between myo‐inositol and placebo groups for the risk of preterm birth or birthweight. One study of 73 infants reported that maternal treatment with myo‐inositol was associated with a reduced risk of neonatal hypoglycaemia and with being born at a later gestational age. This is of potential clinical importance if these results can be confirmed in further studies. No other neonatal outcomes for this review were reported. </p> </section> <section id="CD012048-sec-0128"> <h3 class="title" id="CD012048-sec-0128">Overall completeness and applicability of evidence</h3> <p>The evidence is limited in terms of the number of studies available (n = 2), and in the lack of data reported for the majority of outcomes pre‐specified for this review. </p> </section> <section id="CD012048-sec-0129"> <h3 class="title" id="CD012048-sec-0129">Quality of the evidence</h3> <p>Overall, the risk of bias of the included studies was judged to be unclear due to lack of key methodological information. </p> <p>The quality of the evidence, where it was able to be judged was low. Downgrading of the quality of evidence was mainly due to imprecision (small sample size, single trial and low events) (<a href="./full#CD012048-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD012048-tbl-0002">summary of findings Table 2</a>). None of the maternal outcomes selected for judgement using GRADE had data reported. For the neonatal outcomes selected for GRADE only large‐for‐gestational age and neonatal hypoglycaemia had data reported. </p> </section> <section id="CD012048-sec-0130"> <h3 class="title" id="CD012048-sec-0130">Potential biases in the review process</h3> <p>We conducted a thorough search of multiple databases including trial registries and sought both published and unpublished reports without restrictions in language or date of publication. Identification, data extraction and data entry were performed independently by two review authors. </p> </section> <section id="CD012048-sec-0131"> <h3 class="title" id="CD012048-sec-0131">Agreements and disagreements with other studies or reviews</h3> <p>Minimal literature was found on the use of myo‐inositol for the treatment of gestational diabetes mellitus (GDM). One non‐randomised pilot study (n = 60) (<a href="./references#CD012048-bbs2-0027" title="LubinV , ShojaiR , DarmonP , CossonE . A pilot study of gestational diabetes mellitus not controlled by diet alone: First line medical treatment with myoinositol may limit the need for insulin. Diabetes and Metabolism2016; Vol. 42, issue 3:192‐5. [DOI: 10.1016/j.diabet.2016.01.005] ">Lubin 2016</a>) suggested that in women with GDM who were not well‐controlled with diet alone, myo‐inositol appeared to be a safe first‐line treatment with no adverse side effects. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD012048-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD012048-fig-0001" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD012048-fig-0002" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD012048-fig-0003" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 1 Large‐for‐gestational age." data-id="CD012048-fig-0004" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 1 Large‐for‐gestational age.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 2 Weight gain during pregnancy (kg)." data-id="CD012048-fig-0005" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 2 Weight gain during pregnancy (kg).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 3 Body mass index change (kg/m2)." data-id="CD012048-fig-0006" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 3 Body mass index change (kg/m2).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 4 Additional pharmacological treatment (insulin therapy)." data-id="CD012048-fig-0007" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 4 Additional pharmacological treatment (insulin therapy). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 5 Fasting OGTT (mmol/L)." data-id="CD012048-fig-0008" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 5 Fasting OGTT (mmol/L).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 6 1‐hour OGTT (mmol/L)." data-id="CD012048-fig-0009" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 6 1‐hour OGTT (mmol/L).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 7 2‐hour OGTT (mmol/L)." data-id="CD012048-fig-0010" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 7 2‐hour OGTT (mmol/L).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 8 Gestational age at birth (weeks)." data-id="CD012048-fig-0011" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 8 Gestational age at birth (weeks).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 9 Preterm birth (less than 37 weeks' gestation)." data-id="CD012048-fig-0012" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 9 Preterm birth (less than 37 weeks' gestation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 10 Birthweight (g)." data-id="CD012048-fig-0013" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 10 Birthweight (g).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD012048-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/urn:x-wiley:14651858:media:CD012048:CD012048-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_t/tCD012048-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Myo‐inositol versus placebo, Outcome 11 Neonatal hypoglycaemia." data-id="CD012048-fig-0014" src="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Myo‐inositol versus placebo, Outcome 11 Neonatal hypoglycaemia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/media/CDSR/CD012048/image_n/nCD012048-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD012048-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Setting:</b> women were out‐patients attending a high risk pregnancy unit at hospitals in Italy. </p> <p><b>Patient or population:</b> pregnant women with gestational diabetes<br/> <b>Intervention:</b> 4 g myo‐inositol + 400 mcg folic acid orally per day (dosage regimen not stated), and exercise and dietary advice (n = 36)<br/> <b>Comparison:</b> placebo 400 mcg folic acid orally per day, and exercise and dietary advice (n = 39) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Myo‐inositol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Large‐for‐gestational age</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>26 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>9 per 1000<br/> (1 to 226) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.36<br/> (0.02 to 8.58) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low event rates and small sample size indicate imprecision. 0/35 events in myo‐inositol group and 1/38 events in the placebo group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perinatal mortality</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neonatal hypoglycaemia</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>263 per 1000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>13 per 1000<br/> (0 to 224) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.05<br/> (0.00 to 0.85) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>73<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low event rates and small sample size indicate imprecision. 0/35 events in myo‐inositol group and 10/38 events in the placebo group. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Composite outcome of serious neonatal outcomes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Childhood/adulthood adiposity</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Childhood/adulthood diabetes</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neurosensory disability</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Small sample size, single trial and low events indicate imprecision ‐ downgraded ‐ 2 levels </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Neonatal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD012048-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Setting:</b> women were out‐patients attending a high risk pregnancy unit at a hospital in Italy. </p> <p><b>Patient or population:</b> pregnant women with gestational diabetes<br/> <b>Intervention:</b> 4 g myo‐inositol + 400 mcg folic acid orally per day (dosage regimen not stated), and exercise and dietary advice (n = 36)<br/> <b>Comparison:</b> placebo 400 mcg folic acid orally per day, and exercise and dietary advice (n = 39) </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with Myo‐inositol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hypertensive disorders of pregnancy</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Caesarean section</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Induction of labour</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Perineal trauma</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal weight retention/return to pre‐pregnancy weight</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postnatal depression</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Development of subsequent type 2 diabetes mellitus</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>(0 studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were reported for this outcome.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Myo‐inositol versus placebo for the treatment of gestational diabetes ‐ Maternal outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012048-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Diagnostic criteria for GDM</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Organisation</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Testing schedule</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Abnormal</b> </p> <p><b>values</b> </p> <p><b>required for diagnosis</b> </p> <p><b>of GDM</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>Threshold equal to or greater than</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Fasting</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 hour</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>2 hours</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 hours</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Australasian Diabetes in Pregnancy Society (<a href="./references#CD012048-bbs2-0032" title="NankervisA , McIntyreHD , MosesR , RossGP , CallawayL , PorterC , et al. for the Australasian Diabetes in Pregnancy Society (ADIPS). Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia. URL: http://adips.org/downloads/ADIPSConsensusGuidelinesGDM‐03.05.13VersionACCEPTEDFINAL.pdf (accessed 03 July 2015). ">Nankervis 2013</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>American Diabetes Association (<a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p>American College of</p> <p>Obstetricians and Gynecologists* (<a href="./references#CD012048-bbs2-0006" title="American College of Obstetricians and Gynecologists. Gestational Diabetes Mellitus: Practice Bulletin Number 137. Obstetrics and Gynecology2013;122(2 Pt 1):406‐16. ">ACOG 2013</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either Carpenter &amp; Coustan</p> <p>100 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> <p>mmol/L</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>or NDDG</p> <p>100 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.8</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.2</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.0</p> <p>mmol/L</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>International Association of Diabetes and Pregnancy Study Groups (<a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>World Health Organization (<a href="./references#CD012048-bbs2-0008" title="AlbertiK , ZimmetP . Definition, diagnosis and classification of diabetes mellitus. Part 1: Diagnosis and classification of diabetes mellitus: World Health Organization Report. Diabetic Medicine1998;15(7):539‐53. ">Alberti 1998</a>) </p> <p>National Institute for Health and Care Excellence (<a href="./references#CD012048-bbs2-0035" title="National Institute for Health and Care Excellence. Diabetes in Pregnancy: Management of Diabetes and its Complications from Pre‐conception to the Postnatal Period. Manchester: NICE, 2015. ">NICE 2015</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1 mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Canadian Diabetes Association (<a href="./references#CD012048-bbs2-0013" title="Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. Canadian Journal of Diabetes2008;32(Suppl 1):S1‐S201. ">CDA 2008</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.9</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>New Zealand Ministry of Health (<a href="./references#CD012048-bbs2-0034" title="New Zealand Ministry of Health. Screening, Diagnosis and Management of Gestational Diabetes in New Zealand: A Clinical Practice Guideline. Wellington, New Zealand: Ministry of Health, 2014. ">New Zealand Ministry of Health 2014</a>) </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75 g OGTT</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> <p>mmol/L</p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>–</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>OGTT: oral glucose tolerance test</p> <p>* American College of Obstetricians and Gynecologists stipulates that either the Carpenter and Coustan or the National Diabetes Data Group (NDDG) thresholds are appropriate to use. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Diagnostic criteria for GDM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012048-tbl-0004"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Diagnostic criteria used in included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study ID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Timing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Criteria</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012048-bbs2-0001" title="CorradoF , D'AnnaR , diViesteG , GiordanoD , PintaudiB , SantamariaA , et al. The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabetic Medicine2011;28(8):972‐5. NCT00734448 . Myo‐inositol administration in gestational diabetes. clinicaltrials.gov/show/NCT00734448 Date first received: 16 April 2008. ">Corrado 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 to 28 weeks'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At least 2 abnormal plasma glucose values following</p> <p>100 g OGTT</p> <p>Fasting: ≥ 5.3 mmol/L (≥ 95 mg/dL)</p> <p>1 hour: ≥ 10.0 mmol/L (≥ 180 mg/dL)</p> <p>2 hour: ≥ 8.6 mmol/L (≥ 155 mg/dL)</p> <p>3 hour: ≥ 7.8 mmol/L (≥ 140 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(<a href="./references#CD012048-bbs2-0007" title="American Diabetes Association. Standards of medical care in diabetes. Diabetes Care2008;31(Suppl 1):S55‐S60. ">ADA 2008</a>) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD012048-bbs2-0002" title="MatarrelliB , VitacolonnaE , D'AngeloM , PavoneG , CelentanoC . Early treatment of gestational diabetes and obstetric adverse outcome prevention. Ultrasound in Obstetrics &amp; Gynecology2011;38(Suppl 1):54. MatarrelliB , VitacolonnaE , D'angeloM , PavoneG , MatteiPA , LiberatiM , et al. Effect of dietary myo‐inositol supplementation in pregnancy on the incidence of maternal gestational diabetes mellitus and fetal outcomes: a randomized controlled trial. Journal of Maternal‐Fetal &amp; Neonatal Medicine2013;26(10):967‐72. NCT01342874 . Improved outcomes associated with inositol dietary supplementation in women with gestational diabetes mellitus (inositol). clinicaltrials.gov/show/NCT01342874 Dare first received: 19 April 2011. ">Matarrelli 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 to 28 weeks'</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One or more abnormal blood glucose values following</p> <p>75 g OGTT</p> <p>Fasting: &gt; 5.1 mmol/L (&gt; 92 mg/dL)</p> <p>1 hour: &gt; 10.0 mmol/L (&gt; 180 mg/dL)</p> <p>2 hour: &gt; 8.5 mmol/L (&gt; 153 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(<a href="./references#CD012048-bbs2-0023" title="International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care2010;33(3):676‐82. ">IADPSG 2010</a>) </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Diagnostic criteria used in included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD012048-tbl-0005"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">ADA 2008 Treatment targets used in included trials</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Fasting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1‐hour post‐prandial</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2‐hour post‐prandial</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>&lt; 5.8 mmol/L (&lt; 105 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Either</p> <p>&lt; 8.6 mmol/L (&lt; 155 mg/dL)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Or</p> <p>&lt; 7.2 mmol/L (&lt; 130 mg/dL)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">ADA 2008 Treatment targets used in included trials</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/full#CD012048-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD012048-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Myo‐inositol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Large‐for‐gestational age <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Weight gain during pregnancy (kg) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐3.25, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Body mass index change (kg/m2) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.5 [‐2.35, ‐0.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Additional pharmacological treatment (insulin therapy) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.08, 1.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Fasting OGTT (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.47 [‐0.59, ‐0.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 1‐hour OGTT (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐1.73, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 2‐hour OGTT (mmol/L) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.70 [‐1.46, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Gestational age at birth (weeks) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.10 [1.27, 2.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Preterm birth (less than 37 weeks' gestation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.09, 10.56]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Birthweight (g) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.0 [‐209.72, 241.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Neonatal hypoglycaemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Myo‐inositol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD012048.pub2/references#CD012048-tbl-0006">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD012048.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD012048-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD012048-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD012048-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD012048-note-0005">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD012048-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD012048-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD012048-note-0006">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD012048-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD012048-note-0003">ภาษาไทย</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012048\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012048\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012048\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD012048\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD012048\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=18M35a5z&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012048.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD012048.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD012048.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD012048.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD012048.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727295615"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012048.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727295619"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD012048.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea8934f2e9377',t:'MTc0MDcyNzI5NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 